To reduce the muscarinic side effects of oral forms of cholinesterase inhibitors they should be administered

Questions 105

ATI RN

ATI RN Test Bank

Central and Peripheral Nervous System Drugs Questions

Question 1 of 5

To reduce the muscarinic side effects of oral forms of cholinesterase inhibitors they should be administered

Correct Answer: B

Rationale: The correct answer is B) With food or milk. Cholinesterase inhibitors are used to increase the levels of acetylcholine in the brain by inhibiting its breakdown. However, these medications can lead to unwanted muscarinic side effects such as nausea, vomiting, and diarrhea due to increased cholinergic activity in the body. Administering cholinesterase inhibitors with food or milk can help reduce these side effects by slowing down the absorption of the medication in the gastrointestinal tract, thereby decreasing the peak plasma concentration and minimizing the stimulation of muscarinic receptors. Option A) On an empty stomach is incorrect because taking cholinesterase inhibitors without food can lead to faster absorption and higher peak plasma concentrations, increasing the likelihood of experiencing muscarinic side effects. Option C) With milk is not the ideal choice because while milk can delay gastric emptying, it may not be as effective as a full meal in slowing down drug absorption and reducing muscarinic side effects. Option D) One hour after food is also incorrect as waiting for an hour after eating may not provide enough time for the food to interact with the medication in the stomach and delay its absorption adequately. In an educational context, understanding the optimal administration of medications is crucial for healthcare professionals to ensure the efficacy and safety of treatment. Teaching students about the importance of drug-food interactions can help them make informed decisions when managing patients on cholinesterase inhibitors and other medications with specific administration requirements.

Question 2 of 5

d-Amphetamine has most prominent

Correct Answer: D

Rationale: d-Amphetamine is a central nervous system (CNS) stimulant that primarily exerts its effects by increasing the release of neurotransmitters like dopamine and norepinephrine in the brain. Therefore, the correct answer is D) CNS excitatory effects. Option A) Beta1 effects and B) Beta2 effects refer to the stimulation of beta-adrenergic receptors, which are not the primary mechanism of action for d-Amphetamine. Similarly, option C) Metabolic effects are not the most prominent effects of d-Amphetamine use. Educationally, understanding the specific effects of d-Amphetamine on the CNS is crucial for healthcare professionals, particularly in fields like psychiatry, neurology, and addiction medicine. Knowing that d-Amphetamine primarily exerts CNS excitatory effects can help in making informed decisions regarding its clinical use, potential side effects, and interactions with other medications. This knowledge is essential for providing safe and effective patient care.

Question 3 of 5

A 54-year-old woman suffering from initial insomnia was prescribed a hypnotic drug that increases the activity of a major neurotransmitter system in the brain. Which neurotransmitter system was most likely involved in the therapeutic action of that drug?

Correct Answer: D

Rationale: The correct answer is D: GABAergic. GABA is the major inhibitory neurotransmitter in the brain, and drugs that enhance GABA activity, such as benzodiazepines, are commonly used as hypnotics to treat insomnia. By increasing GABAergic activity, the drug helps to promote relaxation and induce sleep. Choices A, B, and C are incorrect because they do not directly relate to the therapeutic action of hypnotic drugs for insomnia. Cholinergic, noradrenergic, and glutamatergic systems are not primarily involved in promoting sleep and reducing insomnia symptoms.

Question 4 of 5

Which of the following neurotransmitters has been most consistently implicated in the patient's disorder?

Correct Answer: A

Rationale: The correct answer is A: Acetylcholine. Acetylcholine is most consistently implicated in disorders like Alzheimer's disease due to its role in memory and cognitive functions. Dysfunction in acetylcholine signaling is a hallmark of this disorder. Norepinephrine is primarily involved in the stress response, GABA in regulating anxiety, and serotonin in mood regulation. However, acetylcholine's direct association with cognitive impairment makes it the most likely neurotransmitter involved in the patient's disorder.

Question 5 of 5

Which of the following symptoms did the patient most likely experience upon recovery from sedation?

Correct Answer: C

Rationale: The correct answer is C: Anterograde amnesia. Upon recovery from sedation, the patient most likely experienced anterograde amnesia, which is the inability to form new memories after sedation. This occurs due to the effects of sedative medications on the brain's ability to encode and store new information temporarily. This symptom is commonly associated with sedative medications and is a typical outcome of sedation procedures. A: Nausea and vomiting are common side effects of sedation but are more likely to occur during or shortly after sedation, rather than upon recovery. B: Increased respiratory rate may occur during sedation due to the effects of sedative medications on the respiratory system, but it is not a typical symptom upon recovery. D: Limb muscle spasms are not typically associated with recovery from sedation and are more likely to be a sign of a different medical condition or side effect of a different medication.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions